Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Sara Merlo x
  • Refine by access: All content x
Clear All Modify Search
Sara Merlo Department of Experimental and Clinical Pharmacology, DISCAFF, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy
Department of Experimental and Clinical Pharmacology, DISCAFF, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy

Search for other papers by Sara Merlo in
Google Scholar
PubMed
Close
,
Giuseppina Frasca Department of Experimental and Clinical Pharmacology, DISCAFF, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy

Search for other papers by Giuseppina Frasca in
Google Scholar
PubMed
Close
,
Pier Luigi Canonico Department of Experimental and Clinical Pharmacology, DISCAFF, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy

Search for other papers by Pier Luigi Canonico in
Google Scholar
PubMed
Close
, and
Maria Angela Sortino Department of Experimental and Clinical Pharmacology, DISCAFF, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy

Search for other papers by Maria Angela Sortino in
Google Scholar
PubMed
Close

Estrogen affects proliferation and migration of different skin components, thus influencing wound healing processes. The human keratinocyte cell line NCTC 2544 has been used to examine the effects of estrogen, dissect its mechanism of action and characterize receptor subtypes involved. Western blot and immunocytochemical analyses confirmed the expression of estrogen receptors (ERs) α and β, with prevalence in the nuclear and extranuclear compartment, for ERα and ERβ respectively. Treatment with 10 nM 17β-estradiol (17β-E2) and the ERα and ERβ selective agonists, 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole (PPT; 100 nM), and diarylpropionitrile (DPN; 1 nM) produced a slight but significant increase in cell proliferation, as by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and bromodeoxyuridine incorporation assays, only after a long-term treatment (96 h). Analysis of cell migration by a scratch wound assay showed that 17β-E2 (10 nM) accelerated migration between 5 and 24 h after scratching, an effect confirmed by the transwell migration assay. PPT and DPN elicited similar effects. Pre-treatment with the mitogen-activated protein kinase inhibitor, U0126 (1 μM), abolished the ability of 17β-E2 and DPN, but not of PPT, to accelerate wound closure. TGF-β1 (10 ng/ml) produced a similar positive effect on wound closure and the TGF-β1 receptor antagonist, SB431542 (10 μM), reduced the ability of 17β-E2 and PPT to accelerate cell migration, but did not modify DPN effect. It is suggested that estrogen positively affects in vitro wound healing by stimulating cell proliferation after long-term exposure but mainly by accelerating cell migration within a few hours from treatment. Selective activation of ERβ may result in favorable stimulation of wound healing without any increase of transforming growth factor-β1 production.

Free access